Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden

被引：0
|
作者：
Johan Jendle
Jayne Smith-Palmer
Alexis Delbaere
Simona de Portu
Natalie Papo
William Valentine
Stéphane Roze
机构：
[1] Örebro University,
[2] Ossian Health Economics and Communications,undefined
[3] Medtronic International Trading Sarl,undefined
[4] HEVA HEOR,undefined
来源：
Diabetes Therapy | 2017年 / 8卷
关键词：
Cost; Cost-effectiveness; Type 1 diabetes; Sensor-augmented pump therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1015 / 1030
页数：15
相关论文
共 50 条
  • [21] HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH TYPE 1 DIABETES AND IMPAIRED HYPOGLYCAEMIA AWARENESS: THE ROLE OF SENSOR-AUGMENTED INSULIN PUMP THERAPY WITH AUTOMATED INSULIN SUSPENSION
    McBride, M.
    Eggleston, A. S.
    Jones, T.
    Ly, T.
    VALUE IN HEALTH, 2013, 16 (07) : A448 - A448
  • [22] COST EFFECTIVENESS OF SENSOR AUGMENTED PUMP THERAPY WITH AUTOMATED INSULIN SUSPENSION IN THE MANAGEMENT OF TYPE 1 DIABETES (T1D) IN BULGARIA
    Saltik, A. Z. Ozdemir
    Yu, J.
    Toth, J.
    Dacheva, A.
    Slavchev, G.
    Cohen, O.
    VALUE IN HEALTH, 2023, 26 (12) : S52 - S52
  • [23] Faster-acting insulin Fiasp versus insulin Novorapid in type 1 diabetes children and adolescents with sensor-augmented pump therapy
    Xatzipsalti, Maria
    Triantafillidou, Antigoni
    Kourousi, Giannoula
    Patouni, Konstantina
    Bourousis, Evangelos
    Kassari, Elisavet
    Delis, Dimitrios
    Vazeou, Andriani
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 182 - 182
  • [24] Advantages of sensor-augmented insulin pump therapy for pregnant women with type?1 diabetes mellitus
    Imafuku, Hitomi
    Tanimura, Kenji
    Masuko, Naohisa
    Tomimoto, Masako
    Shi, Yutoku
    Uchida, Akiko
    Deguchi, Masashi
    Fujioka, Kazumichi
    Yamamoto, Akane
    Yoshino, Kei
    Hirota, Yushi
    Ogawa, Wataru
    Terai, Yoshito
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (12) : 1383 - 1390
  • [25] THE APPLICATION OF DISCRETE CHOICE EXPERIMENTS IN COST-EFFECTIVENESS STUDIES TO ASSESS THE BENEFITS OF SENSOR-AUGMENTED INSULIN PUMP THERAPY FOR THE TREATMENT OF TYPE 1 DIABETES
    Barnett, N.
    Geelhoed, E.
    Davis, E.
    Jones, T. W.
    De Bock, M.
    Smith, G.
    Norman, R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A101 - A101
  • [26] Cost-Effectiveness of Sensor-Augmented Pump Therapy in Adults with Type 1 Diabetes in the United States
    Kamble, Shital
    Schulman, Kevin A.
    Reed, Shelby D.
    VALUE IN HEALTH, 2012, 15 (05) : 632 - 638
  • [27] Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes (vol 363, pg 311, 2010)
    Bergenstal, Richard M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (11): : 1092 - 1092
  • [28] INCORPORATION OF THE SENSOR-AUGMENTED INSULIN-PUMP THERAPY INTO THE UVA/PADOVA TYPE 1 DIABETES SIMULATOR
    Visentin, R.
    Vettoretti, M.
    Facchinetti, A.
    Dalla Man, C.
    Sparacino, G.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A130 - A130
  • [29] PATIENT TIME AND INDIRECT COSTS ASSOCIATED WITH SENSOR-AUGMENTED INSULIN PUMP THERAPY IN TYPE 1 DIABETES
    Kamble, S.
    Weinfurt, K. P.
    Perry, B. M.
    Schulman, K. A.
    Reed, S. D.
    VALUE IN HEALTH, 2011, 14 (03) : A84 - A84
  • [30] HEALTH-ECONOMIC EVALUATION OF SENSOR-AUGMENTED PUMP (SAP) VERSUS INSULIN PUMP THERAPY ALONE (CSII), IN TYPE 1 DIABETES PATIENTS, IN ITALY
    Roze, S.
    Duteil, E.
    Naclerio, M.
    D'Ostilio, D.
    De Portu, S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A41 - A41
12345